Laura Angelats

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Genomic and clinical features in young women with estrogen receptor-positive, HER2-negative breast cancer.

Genomic and clinical features in young women with estrogen receptor-positive, HER2-negative breast cancer.

Journal: ESMO open

Published: April 28, 2025

HER2DX ERBB2 score in advanced HER2-positive gastric cancer treated with trastuzumab and chemotherapy.

HER2DX ERBB2 score in advanced HER2-positive gastric cancer treated with trastuzumab and chemotherapy.

Journal: ESMO open

Published: April 23, 2025

Unlocking the potential of engineered immune cell therapy for solid tumors.

Unlocking the potential of engineered immune cell therapy for solid tumors.

Journal: Nature communications

Published: November 22, 2024

Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study.

Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study.

Journal: Cancer immunology, immunotherapy : CII

Published: September 24, 2024

Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancer.

Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancer.

Journal: ESMO open

Published: August 15, 2024

Unexpected Durable Complete Response With Anti-PD-L1 Blockade in Metastatic Undifferentiated Pleomorphic Sarcoma: A Case Report With Host and Tumor Biomarker Analysis.

Unexpected Durable Complete Response With Anti-PD-L1 Blockade in Metastatic Undifferentiated Pleomorphic Sarcoma: A Case Report With Host and Tumor Biomarker Analysis.

Journal: JCO precision oncology

Published: October 19, 2023

CAR affinity modulates the sensitivity of CAR-T cells to PD-1/PD-L1-mediated inhibition.

CAR affinity modulates the sensitivity of CAR-T cells to PD-1/PD-L1-mediated inhibition.

Journal: Nature communications

Published: October 06, 2023

A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies.

A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies.

Journal: EBioMedicine

Published: September 09, 2023

SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer.

SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: August 07, 2023

Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.

Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.

Journal: Cancer immunology, immunotherapy : CII

Published: February 22, 2023

Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.

Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.

Journal: Cancer immunology, immunotherapy : CII

Published: September 06, 2022

HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1.

HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1.

Journal: Journal of the National Cancer Institute

Published: July 26, 2022

Showing 1-12 of 12

Last Updated: 09/26/2026